Relationship between EGFR mutation and computed tomography features in patients with non-small cell lung cancer
Main Article Content
Abstract
Objective: The aim of this study is to investigate the relationship between EGFR mutation and computed tomography (CT) features in patients with non-small cell lung cancer (NSCLC).
Material and Methods: Ninety-eight patients who was diagnosed with non-small cell lung cancer (NSCLC) between January 2023 and May 2025 at Thai Nguyen National hospital, had undergone a chest CT and EGFR mutation testing were enrolled in this study. The 98 recruited non small cell lung cancer patients were divided into two groups according to EGFR mutation status: patients with EGFR mutations (n=35) and non-mutated (n=63). The clinical characteristics and CT imaging features of two groups were recorded and compared. Univariate and logistic regression analysis were performed to identify the independent risk factors relevant to EGR gene mutation.
Results: Of 98 patients, 35 (35.7%) were EGFR mutation-positive. The univariate logistic regression indicated that female gender (OR 3.3), lung CT features of halo sign (OR 5.186), pleural retraction (OR 2,779) and pleural effusion (OR 4.15) were independent risk factors relevant to EGFR mutation.
Conclusion: Female patients with lung CT features of halo sign, pleural retraction and pleural effusion are more prone to harbor EGFR gene mutation and are more likely to benefit from targeted therapy.
Keywords
CT, EGFR, Lung cancer.
Article Details
References
2 Hisao Imai, Kyoichi Kaira & Koichi Minato. Clinical significance of post-progression survival in lung cancer. Thoracic Cancer 8, 379-386 (2017).
3 Tony S Mok et al. Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma. New England Journal of Medicine 361, 947-957 (2009).
4 Ho Yun Lee & Kyung Soo Lee. Ground-glass opacity nodules: histopathology, imaging evaluation, and clinical implications. Journal of thoracic imaging 26, 106-118 (2011).
5 Liu Ying et al. CT features associated with epidermal growth factor receptor mutation status in patients with lung adenocarcinoma. Radiology 280, 271-280 (2016).
6 Xiaoyu Han et al. Value of CT features for predicting EGFR mutations and ALK positivity in patients with lung adenocarcinoma. Scientific reports 11, 5679 (2021).
7 Andrés Felipe Herrera Ortiz et al. Clinical and CT patterns to predict EGFR mutation in patients with non-small cell lung cancer: A systematic literature review and meta-analysis. European Journal of Radiology Open 9, 100400 (2022).
8 Zhang Hanfei, Cai, Weiguo, Wang, Yanfan, Liao, Meiyan & Tian, Sufang. CT and clinical characteristics that predict risk of EGFR mutation in non-small cell lung cancer: a systematic review and meta-analysis. International journal of clinical oncology 24, 649-659 (2019).
9 Jiawei Zou et al. Computed tomography and clinical features associated with epidermal growth factor receptor mutation status in stage I/II l ung adenocarcinoma. Thoracic Cancer 8, 260-270 (2017).
10 Xiaowei Qiu, Yuan, Hang & Sima, Bin. Relationship between EGFR mutation and computed tomography characteristics of the lung in patients with lung adenocarcinoma. Thoracic Cancer 10, 170-174 (2019).
11 Khúc Duy Mạnh, Nguyễn Văn Thi & Đoàn Văn Hoan. Mối liên quan giữa đặc điểm hình ảnh cắt lớp vi tính và tình trạng đột biến gen EGFR ở bệnh nhân ung thư phổi biểu mô tuyến Tạp chí Y học Việt Nam 535 (2024).
12 Zenghui Cheng, Fei Shan, Yuesong Yang, Yuxin Shi & Zhiyong Zhang. CT characteristics of non-small cell lung cancer with epidermal growth factor receptor mutation: a systematic review and meta-analysis. BMC Medical Imaging 17, 1-10 (2017).